Innovative WEF-style forums will gather experts from the corporate, neuroscience, and clinical fields to discuss breakthroughs in neurodegeneration research. These sessions aim to advance our understanding and treatment of Alzheimer’s and Parkinson’s diseases by exchanging new insights and addressing current challenges. Each forum features brief introductions by participants, followed by an audience Q&A, with media coverage to share progress in the field.

Date & Time

Forum Title

Co-Moderators

Discussants

Tuesday, March 17, 2026

17:00 – 18:00

FIRESIDE DEBATE: MOONSHOTS AND MILESTONES: IS THE FUTURE OF NEURODEGENERATION DRUG DISCOVERY IN STARTUPS, BIG PHARMA, OR ACADEMIA?
  • Henrietta Nielsen
  • Phillip Scheltens
  • Geoff Kerchner
  • Mark Mintun

Wednesday, March 18, 2026

14:30 – 15:30

FORUM 01: BIOMARKERS TO BENEFIT: ACCELERATING TRANSLATION OF MULTI-MODAL BIOMARKERS INTO DISEASE-MODIFYING THERAPIES

  • Melissa Murray
  • Oskar Hansson
  • TBA

15:35 – 16:35

FORUM 02: BEYOND ONE SIZE FITS ALL: PRECISION DRUG DEVELOPMENT, AI METHODS, AND TRIAL DESIGN IN AD/PD

  • Randall Bateman
  • Rhoda Au
  • Michael Weiner

  • Jon Walsh

Thursday, March 19, 2026

17:30 – 18:30

FORUM 03: REWIRING COGNITION: TARGETING CHOLINERGIC, SYNAPTIC, AND NETWORK-BASED MECHANISMS IN AD, PD, AND LBD

  • Manfred Windisch
  • Jeffrey Cummings
  • Frank Longo
  • Taylor Schmitz

Friday, March 20, 2026

17:30 – 18:30

FORUM 04: TARGETS TO THERAPIES: TRANSLATIONAL R&D FOR Α-SYNUCLEIN, LRRK2, AND GBA PATHOLOGIES IN PD, LBD, AND MSA

  • Jamie Eberling
  • Kenneth Marek
  • Jose-Alberto Palma
  • Tomislav Babic

Saturday, March 21, 2026

15:30 – 16:30

FORUM 05: IMMUNOTHERAPY 2.0: REDEFINING MICROGLIAL, TREM2, AND ADAPTIVE IMMUNE ENGAGEMENT IN AD AND PD

  • Suzanne Hendrix
  • Henrik Zetterberg
  • Donna Wilcock

14:30 – 15:30

FORUM 06: BEYOND AMYLOID AND TAU: EMERGING TARGETS AND MULTI-PATHWAY APPROACHES IN NEURODEGENERATION AND NEUROINFLAMMATION – PROMISE AND PITFALLS

  • David Holtzman
  • Cynthia Lemere
  • Christian Hölscher
  • Adam Fleisher
VIEW THE FULL PROGRAM